Commons Platform With Michael Kellen and Brig Mecham
APRIL 15, 2011 -- PART 1: ACHIEVEMENTS OF THE PAST YEAR
The second Sage Bionetworks Commons Congress will be held in San Francisco on April 15-16, 2011. The theme will be the move towards personalized, patient-driven medicine, and the role that Sage Bionetworks can play in that transition. Expect reports from the Sage Federation, Working Groups, and exciting projects like SageCite, poster sessions and evening activities.
A patient perspective on healthcare followed by summaries of the new projects that have emerged since the 2010 Congress as a demonstration that the efforts of the Commons over the past year have paid off. The Federation, the Commons Platform, Repository and independent projects like SageCite will be featured. Sage Bionetworks will review its own internal development work and a new journal for sharing models will be announced.
Bio
Michael Kellen
Michael M. Kellen currently serves as vice chairman of Arnhold and S. Bleichroeder Advisers, LLC and as co-president and co-chief executive officer of Arnhold and S. Bleichroeder Holdings, Inc. Kellen is on the Board of Trustees at the Cancer Research Institute.
Brig Mecham
Brig Mecham, PhD is a Postdoctoral Researcher at Sage Bionetworks Development.
Any of a group of more than 100 distinct diseases that are characterized by the uncontrolled multiplication of abnormal cells. Cancerous cells and tissues have abnormal growth rates, shapes, sizes, and functioning. Cancer may progress in stages from a localized tumour (confined to the site of origin) to direct extension (spread into nearby tissue or lymph nodes) and metastasis (spread to more distant sites via the blood or lymphatic system). This malignant growth pattern distinguishes cancerous tumours from benign ones. Cancer is also classified by grade, the extent to which cell characteristics remain specific to their tissue of origin. Both stage and grade affect the chances of survival. Genetic factors and immune status affect susceptibility. Triggers include hormones, viruses, smoking, diet, and radiation. Cancer can begin in almost any tissue, as well as in the blood (seeleukemia) and lymph (seelymphoma). When it metastasizes, it remains a cancer of its tissue of origin. Early diagnosis and treatment increase the chance of cure. Treatment may include chemotherapy, surgery, and radiation therapy. See alsobladder cancer; breast cancer; carcinogen; colorectal cancer; Kaposi sarcoma; laryngeal cancer; lung cancer; ovarian cancer; pancreatic cancer; prostate cancer; skin cancer; stomach cancer; uterine cancer.
The practice concerned with the maintenance of health and the prevention, diagnosis, and treatment of disease. Medicine may be practiced in doctors' offices, health maintenance organization facilities, hospitals, and clinics. In addition to family practice, internal medicine, and specialties for specific body systems, it includes research, public health, epidemiology, and pharmacology. Each country sets its own requirements for medical degrees (M.D.'s) and licenses. Medical boards and councils set standards and oversee medical education. Boards of certification have stringent requirements for physicians seeking to practice a specialty, and they stress continuing education. Advances in therapy (seetherapeutics) and diagnosis have raised complex legal and moral issues in areas such as abortion, euthanasia, and patients' rights. Recent changes include treating patients as partners in their own care and taking cultural factors into consideration.
member. 
Watch Now
